# Home Treatment With Carfilzomib in Patients With Multiple Myeloma

> **NCT05620238** · — · RECRUITING · sponsor: **Thomas Lund** · enrollment: 12 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Carfilzomib

## Key facts

- **NCT ID:** NCT05620238
- **Lead sponsor:** Thomas Lund
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-15
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620238, "Home Treatment With Carfilzomib in Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05620238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*